Patients with high-risk atrial fibrillation, or AFib, often require one drug to regulate heart rhythm and a second drug to thin their blood and reduce the risk of stroke. A recent study led by a University of Missouri School ...
(HealthDay)—Patients who take the heart rhythm drug digoxin may face a nearly 30 percent greater risk of death than patients not taking the drug, a review of prior research suggests.
(HealthDay)—The circadian clock seems to have a significant impact on allergic reaction, according to a review published online Feb. 17 in Allergy.
Scientists from Cardiff and Swansea Universities are combining the principles of the butterfly effect and computer simulation to explore new ways of predicting and controlling the beginnings of heart disease.
(HealthDay)—Implantable cardioverter-defibrillators (ICDs) prolong survival among heart patients who face a high risk for sudden cardiac death, a new review of research indicates.
Imagine being with someone who suddenly collapses and doesn't respond to you.